Distinct and Competitive Regulatory Patterns of Tumor Suppressor Genes and Oncogenes in Ovarian Cancer

Background So far, investigators have found numerous tumor suppressor genes (TSGs) and oncogenes (OCGs) that control cell proliferation and apoptosis during cancer development. Furthermore, TSGs and OCGs may act as modulators of transcription factors (TFs) to influence gene regulation. A comprehensive investigation of TSGs, OCGs, TFs, and their joint target genes at the network level may provide a deeper understanding of the post-translational modulation of TSGs and OCGs to TF gene regulation. Methodology/Principal Findings In this study, we developed a novel computational framework for identifying target genes of TSGs and OCGs using TFs as bridges through the integration of protein-protein interactions and gene expression data. We applied this pipeline to ovarian cancer and constructed a three-layer regulatory network. In the network, the top layer was comprised of modulators (TSGs and OCGs), the middle layer included TFs, and the bottom layer contained target genes. Based on regulatory relationships in the network, we compiled TSG and OCG profiles and performed clustering analyses. Interestingly, we found TSGs and OCGs formed two distinct branches. The genes in the TSG branch were significantly enriched in DNA damage and repair, regulating macromolecule metabolism, cell cycle and apoptosis, while the genes in the OCG branch were significantly enriched in the ErbB signaling pathway. Remarkably, their specific targets showed a reversed functional enrichment in terms of apoptosis and the ErbB signaling pathway: the target genes regulated by OCGs only were enriched in anti-apoptosis and the target genes regulated by TSGs only were enriched in the ErbB signaling pathway. Conclusions/Significance This study provides the first comprehensive investigation of the interplay of TSGs and OCGs in a regulatory network modulated by TFs. Our application in ovarian cancer revealed distinct regulatory patterns of TSGs and OCGs, suggesting a competitive regulatory mechanism acting upon apoptosis and the ErbB signaling pathway through their specific target genes.

[1]  B. Cochran,et al.  Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells , 2003, BMC Cancer.

[2]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[3]  A. Whittemore,et al.  A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 , 2009, Nature Genetics.

[4]  A. Whittemore,et al.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.

[5]  T. Hirano,et al.  STAT3 orchestrates contradictory signals in cytokine‐induced G1 to S cell‐cycle transition , 1998, The EMBO journal.

[6]  Dakang Xu,et al.  Transcriptional Regulation of Telomerase Activity , 2007, Annals of the New York Academy of Sciences.

[7]  Hiroshi Suzuki,et al.  Hemoprotein Bach1 regulates enhancer availability of heme oxygenase‐1 gene , 2002, The EMBO journal.

[8]  Olivier Bodenreider,et al.  The NLM Indexing Initiative , 2000, AMIA.

[9]  A. Noske,et al.  HMGA2 gene is a promising target for ovarian cancer silencing therapy , 2008, International journal of cancer.

[10]  Alexander E. Kel,et al.  MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..

[11]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[12]  P. Jia,et al.  SZGR: a comprehensive schizophrenia gene resource , 2009, Molecular Psychiatry.

[13]  M. Hallek,et al.  Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo , 2010 .

[14]  Ximing J. Yang,et al.  HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma , 2010, Modern Pathology.

[15]  James E. Ferrell,et al.  Systems biology: On the cell cycle and its switches , 2008, Nature.

[16]  Zhongming Zhao,et al.  Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma , 2012, PLoS Comput. Biol..

[17]  T. Visakorpi,et al.  ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells , 2011, PloS one.

[18]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[19]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[20]  M. Evans,et al.  Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. , 2000, Molecular biology of the cell.

[21]  Vladimir B. Bajic,et al.  Database for exploration of functional context of genes implicated in ovarian cancer , 2008, Nucleic Acids Res..

[22]  W. Willett,et al.  A prospective study of reproductive factors and risk of epithelial ovarian cancer , 1995, Cancer.

[23]  Juan M. Vaquerizas,et al.  A census of human transcription factors: function, expression and evolution , 2009, Nature Reviews Genetics.

[24]  G. Feldman,et al.  Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. , 2003, Blood.

[25]  M. Tang,et al.  A Novel Interaction between Procaspase 8 and SPARC Enhances Apoptosis and Potentiates Chemotherapy Sensitivity in Colorectal Cancers* , 2007, Journal of Biological Chemistry.

[26]  N. Takai,et al.  c-Ets1 is a promising marker in epithelial ovarian cancer. , 2002, International journal of molecular medicine.

[27]  E. Wingender,et al.  MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.

[28]  Timothy R. Rebbeck,et al.  Assessing the function of genetic variants in candidate gene association studies , 2004, Nature Reviews Genetics.

[29]  Jun S. Song,et al.  Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activity. , 2008, Cancer research.

[30]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[31]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[32]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[33]  S Beck,et al.  RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer , 2007, Oncogene.

[34]  M. Schwab.  Genetic principles of tumor suppression. , 1989, Biochimica et biophysica acta.

[35]  Tsonwin Hai,et al.  Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis* , 2006, Journal of Biological Chemistry.

[36]  Marc Prentki,et al.  Role for Activating Transcription Factor 3 in Stress-Induced β-Cell Apoptosis , 2004, Molecular and Cellular Biology.

[37]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[38]  Michael Q. Zhang,et al.  Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer , 2011, PloS one.

[39]  Jing Zhu,et al.  Extracting consistent knowledge from highly inconsistent cancer gene data sources , 2010, BMC Bioinformatics.

[40]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[41]  Marc Prentki,et al.  Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. , 2004, Molecular and cellular biology.

[42]  E. Berns,et al.  Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma , 2011, PloS one.

[43]  A. Bilancio,et al.  Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition , 2005, Nature Cell Biology.

[44]  G. Lozano,et al.  E2F3 Is a Mediator of DNA Damage-Induced Apoptosis , 2009, Molecular and Cellular Biology.

[45]  P. Laird,et al.  Genome-Scale Screen for DNA Methylation-Based Detection Markers for Ovarian Cancer , 2011, PloS one.

[46]  R. Bronson,et al.  Selective Requirements for E2f3 in the Development and Tumorigenicity of Rb-Deficient Chimeric Tissues , 2007, Molecular and Cellular Biology.

[47]  A. Whittemore,et al.  Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.

[48]  D. Tripathy,et al.  Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. , 2004, The oncologist.

[49]  Mariano J. Alvarez,et al.  Genome-wide Identification of Post-translational Modulators of Transcription Factor Activity in Human B-Cells , 2009, Nature Biotechnology.

[50]  C. Croce,et al.  Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas , 2002, Oncogene.

[51]  Zeng-Ming Yang,et al.  Signal transducer and activator of transcription 3 (Stat3) expression and activation in rat uterus during early pregnancy. , 2004, Reproduction.

[52]  W. Kang,et al.  E2F-1 is a critical modulator of cellular senescence in human cancer. , 2006, International journal of molecular medicine.

[53]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[54]  V. Beral,et al.  Reproductive factors and risk of ovarian cancer: A prospective study , 1988, International journal of cancer.

[55]  S. Hannenhalli,et al.  Regulating the regulators: modulators of transcription factor activity. , 2010, Methods in molecular biology.

[56]  I. Kockum,et al.  Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias. , 2008, European journal of endocrinology.

[57]  C. Morrison,et al.  Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features , 2011, Breast Cancer Research and Treatment.

[58]  Paul J Hertzog,et al.  Ets1 is required for p53 transcriptional activity in UV‐induced apoptosis in embryonic stem cells , 2002, The EMBO journal.

[59]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[60]  B. Karlan,et al.  Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer , 2008, Oncogene.

[61]  D. Shelton,et al.  Wnt/ß-catenin/Lef-1 signaling in the uterus and its implications in uterine gland formation and cancer development , 2011 .

[62]  Howard A. Fine,et al.  Integration and analysis of genome-scale data from gliomas , 2011, Nature Reviews Neurology.

[63]  T. Nakadai,et al.  TATA-Binding Protein-Like Protein (TLP/TRF2/TLF) Negatively Regulates Cell Cycle Progression and Is Required for the Stress-Mediated G2 Checkpoint , 2003, Molecular and Cellular Biology.

[64]  Peilin Jia,et al.  A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case , 2009, Bioinform..

[65]  P. Leung,et al.  Endocrine signaling in ovarian surface epithelium and cancer. , 2007, Human reproduction update.

[66]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[67]  M. Hallek,et al.  Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. , 2010, Neoplasia.

[68]  Jianmin Wu,et al.  Integrated network analysis platform for protein-protein interactions , 2009, Nature Methods.

[69]  P. Rothberg,et al.  Oncogenes and cancer. , 1983, Cancer investigation.

[70]  Robert C. Bast,et al.  The biology of ovarian cancer: new opportunities for translation , 2009, Nature Reviews Cancer.

[71]  A. Dayton,et al.  Interleukin‐12 treatment down‐regulates STAT4 and induces apoptosis with increasing ROS production in human natural killer cells , 2011, Journal of leukocyte biology.

[72]  J. Gray,et al.  The genetics and genomics of cancer , 2003, Nature Genetics.

[73]  Susanne M. Humphrey,et al.  The NLM Indexing Initiative's Medical Text Indexer , 2004, MedInfo.

[74]  Jun Dong,et al.  Geometric Interpretation of Gene Coexpression Network Analysis , 2008, PLoS Comput. Biol..

[75]  X. Wu,et al.  Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[76]  C. Walker,et al.  Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function. , 2002, Cancer research.

[77]  Peilin Jia,et al.  A comprehensive network and pathway analysis of candidate genes in major depressive disorder , 2011, BMC Systems Biology.

[78]  N. Campbell.  Genetic association database , 2004, Nature Reviews Genetics.

[79]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[80]  H. Risch.  Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. , 1999, Journal of the National Cancer Institute.